Previous Article | Next Article ![]()
Infection and Immunity, December 2001, p. 7635-7641, Vol. 69, No. 12
Department of Molecular Genetics,
Biochemistry and Microbiology, University of Cincinnati, Cincinnati,
Ohio 45267
Received 2 August 2001/Returned for modification 13 September
2001/Accepted 19 September 2001
The potential of human monocytes to mediate the clearance of
Bordetella pertussis infection was examined. Bacteria
expressing green fluorescent protein were incubated with adherent
peripheral blood monocytes, and phagocytosis was quantified by using
fluorescence microscopy. Monocytes internalized only a small percentage
of the adherent bacteria. Surface-associated Bvg-regulated virulence factors, including adenylate cyclase toxin and filamentous
hemagglutinin, did not affect attachment or phagocytosis. However, 1-h
pretreatment with purified pertussis toxin inhibited the ability of
monocytes to internalize wild-type bacteria. Mutations affecting the
terminal trisaccharide of lipopolysaccharide resulted in reduced
internalization without affecting adherence of bacteria to monocytes.
Opsonization with human serum played only a modest role in promoting
phagocytosis. The viability of internalized bacteria was determined by
colony counts following treatment with polymyxin B and gentamicin. Less than 1% of internalized bacteria remained viable. These results suggest that pertussis toxin plays a role in the evasion of monocyte phagocytosis and that these cells represent a potential mediator of the
clearance of B. pertussis infection.
The gram-negative bacterium
Bordetella pertussis, the causative agent of whooping cough,
is transmitted via an airborne route, usually by respiratory droplets
expelled by an infected individual during a coughing paroxysm. The
bacteria colonize the ciliated cells of the human upper respiratory
tract. Even in a nonimmunized host, B. pertussis will
encounter a number of innate immune defenses. One of the earliest
immune responses is the recruitment of phagocytic cells. In particular,
neutrophils and monocytes (progenitors of macrophages) cross from the
bloodstream into the respiratory mucosa in response to infection. Once
present, these cells are capable of binding to and internalizing
invading bacterial cells. Internalization is often followed by a
respiratory burst, which can potentially kill the internalized
microorganisms. In vivo studies in mice suggest phagocytic cells can
play an important role in clearing B. pertussis infection
(21, 34). One study demonstrated that, following challenge
with live B. pertussis organisms, there was a dramatic
increase in the numbers of neutrophils and lymphocytes present in the
lungs of both unimmunized mice and mice previously immunized with
whole-cell pertussis vaccine (30). In mice immunized with
an acellular vaccine, an influx of macrophages was observed in response
to infection (30).
Previous work has demonstrated that, although capable of readily
binding B. pertussis, human neutrophils are inefficient at internalizing the bacteria. All of the bacteria were found associated with the neutrophils, but only about 15% were actually phagocytosed (27, 42). This inefficiency, and not an inability to kill internalized bacteria, makes this defense only minimally effective against B. pertussis. In fact, once internalized, only about
1.7% of the phagocytosed bacteria survived after 2 h
(27). Specific virulence factors were found to affect
phagocytosis by neutrophils. Attachment was mediated by filamentous
hemagglutinin (FHA); however, attachment via opsonizing antibody, not
FHA, was essential for internalization (42). Additionally,
it was found that the B. pertussis adenylate cyclase toxin
was important in crippling the phagocytic functions of neutrophils,
since internalization only occurred in the presence of neutralizing
antibodies to adenylate cyclase toxin (41) when an
adenylate cyclase toxin mutant was used (42) or when
adenylate cyclase toxin was inactivated by treatment with fluorescein
isothiocyanate (FITC) (39).
Contrary to this clear picture of phagocytosis of B. pertussis by human neutrophils, a comparable model has not been
developed for monocytes and macrophages. Monocytes are among the first
responders to a B. pertussis infection and represent cells
in the earliest stages of differentiation into macrophages. Although
there are a number of differences between the two cell types, the two
possess a number of common receptors and signaling pathways. Shortly
after adherence, monocytes begin to mature into macrophages, and the distinction between the two cell types (adherent monocytes and macrophages) becomes less clear.
Initial reports suggested that B. pertussis is capable of
surviving within monocytes and macrophages. One study used endogenous complement to kill extracellular B. pertussis
(15). B. pertussis is only susceptible to
antibody-dependent killing by complement (14), and the
reported survival was possibly due to a failure of serum from donors
with a different immune status to kill all of the extracellular
bacteria. All other published reports have used antibiotics to kill
extracellular bacteria. Intracellular phenotypic modulation within
macrophages has been suggested to be a bacterial adaptation to enhance
intracellular survival (28, 29). However, a 2 log drop in
bacterial viability was reported (28, 29), and these
studies focused on the 1% of the viable bacteria recovered following
phagocytosis, not the 99% that were killed by the macrophages. In
another study, significant numbers of viable intracellular
Bordetella bronchiseptica organisms were recovered from
macrophages after 4 days of incubation, but B. pertussis was
eliminated by about 24 h (4). Thus, the only study to
report significant long-term intracellular survival of B. pertussis was the study that used a highly variable reagent, complement plus antibody, instead of antibiotics to kill the
extracellular bacteria.
It is likely that phagocytosis by macrophages could play an important
role in clearing infections by B. pertussis. Previous studies have reported a role for FHA, pertactin, and fimbriae in
influencing attachment and phagocytosis by monocytes (17-19, 21,
23). In these studies B. pertussis was added to
adherent monocytes in culture and centrifugation was not used to
promote contact between the bacteria and the monocytes. B. pertussis in suspension does not settle significantly, even over
several hours (27). Random collisions must bring the
suspended bacteria into contact with the monocytes, and association is
most likely to be maintained with bacteria that mediate their own
adherence or adhere via the Fc receptors on antibodies, leading to
increased phagocytosis of strains that mediate their own adherence
(27). However in the human body, monocytes are motile and
are capable of pursuing bacteria. Centrifugation has been shown to
enhance contact between B. pertussis and adherent cells in
culture and eliminate the bias towards phagocytosis of adherent
bacteria (27), and it may more accurately reflect events
in vivo.
We examined the ability of adherent human monocytes to internalize and
kill B. pertussis bacteria expressing different virulence factors. In this study, increased phagocytosis of strains expressing adhesins and opsonized bacteria was observed for bacteria in suspension but not when the bacteria were centrifuged to promote association with
the monocytes. Only pertussis toxin and lipopolysaccharide (LPS)
influenced phagocytosis by monocytes when centrifugation was used to
enhance contact. The ability of the bacteria to survive following
internalization was also examined, and less than 1% of the
internalized bacteria remained viable.
Bacterial strains and growth conditions.
Plasmids and
bacterial strains used in this study are described in Table
1. B. pertussis strains
expressing green fluorescent protein (GFP) were grown in Stainer
Scholte (SS) broth on Bordet Gengou (BG) agar (Difco, Detroit, Mich.)
plates for 24 h as described previously (11).
Briefly, strains were suspended in 7 ml of SS broth containing the
appropriate selective antibiotics to an optical density at 600 nm
(OD600) of approximately 0.1, overlaid on BG agar
plates containing 15% defibrinated sheep's blood (Colorado Serum
Company, Denver, Colo.) and appropriate antibiotics, and incubated at
37°C for 24 h.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7635-7641.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Pertussis Toxin and Lipopolysaccharide Influence
Phagocytosis of Bordetella pertussis by Human
Monocytes
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Bacterial plasmids and strains used in this study
Antibody opsonization. Antibody was obtained from whole human serum pooled from six adult volunteers. The pooled serum had antibodies specific to B. pertussis, as determined by Western blotting, and the ability to mediate antibody-dependent complement killing (data not shown). Pooled serum was incubated for 30 min at 56°C to heat-inactivate the complement. Bacteria were pelleted by centrifugation and resuspended in 15 µl of serum and incubated for 15 min at 37°C prior to addition to monocyte cultures.
Adherent monocytes. Monocytes were isolated from healthy adult volunteers. Blood was collected by venipuncture, combined with 0.11 ml of 3.8% sodium citrate per ml of blood to prevent coagulation, and centrifuged for 20 min at 100 × g to remove plasma. Total white blood cells were separated from the remaining whole blood by incubation for 1 h with a final concentration of 0.6% dextran in 0.9% saline. Peripheral blood mononuclear cells were isolated from this layer by centrifugation over Ficoll-Paque (Amersham Pharmacia, Uppsala, Sweden) gradients at 450 × g for 25 min. Isolated mononuclear cells were further purified on Percoll gradients, formed by centrifuging 7 ml of Percoll (Sigma, St. Louis, Mo.) and 6 ml of 2× phosphate-buffered saline (PBS) at 27,000 × g for 40 min. Mononuclear cells were layered on the gradient and centrifuged for 20 min at 1,000 × g. Following centrifugation four bands were observed, and the second band from the top contained mostly monocytes, as had been reported previously (38). Monocytes were suspended at 6 × 106 cells per ml in Hanks' buffered salt solution (BioWhittaker, Rockland, Md.) buffered with 10 mM HEPES (Sigma) (H-H), and autologous serum (0.001%). One milliliter was plated in each well of a sterile 24-well tissue culture dish containing glass coverslips. Plates were incubated for 1 h at 37°C, 5% CO2 for 1 h to allow adherence.
Phagocytosis assay. To determine the number of bacteria phagocytosed by human monocytes, we used an assay similar to that previously described for human neutrophils (39). Bacteria expressing GFP were grown in SS on BG, washed, and resuspended to an OD600 of approximately 1.0 in H-H. This bacterial suspension (15 µl, or approximately 3 × 107 cells) was diluted to 400 µl and added to each well containing adherent monocytes to achieve a multiplicity of infection (MOI) of approximately 5.
For all experiments, except where indicated, the plates were then centrifuged for 5 min at 640 × g to facilitate contact between bacteria and adherent monocytes. Plates were incubated for 1 h at 37°C, 5% CO2 to allow phagocytosis to occur. Wells were washed several times with H-H to remove any nonadherent bacterial cells. Cultures were stained for 10 min with 0.5 ml of a 0.05-mg/ml solution of ethidium bromide in H-H. Wells were washed twice to remove any residual ethidium bromide and fixed overnight at 4°C in a 0.01 M phosphate buffer-1% paraformaldehyde fixative. Coverslips were washed, mounted on microscope slides with 5% glycerol in PBS, and sealed using clear nail varnish. Slides were observed by using fluorescence microscopy. Previous studies have shown that in the short duration of the staining, internalized bacteria expressing GFP resist staining with ethidium bromide and appear green, while noninternalized, adherent bacteria stain orange (39). The numbers of adherent and internalized bacteria were counted for 100 monocytes per coverslip, performed in triplicate, with at least three independent repetitions. Statistical analysis was performed using the paired Student t test.Pertussis toxin pretreatment. Monocytes were isolated and allowed to adhere as described above. Adherent monocytes were incubated with purified pertussis toxin or purified B-oligomer (List Biologicals, Campbell, Calif.) for 1 h at 37°C, 5% CO2. After this incubation, bacterial suspensions were added and phagocytosis assays were performed as described above.
Intracellular survival assay. Assays similar to those previously used for human neutrophils were performed to assess the intracellular survival of B. pertussis (27). Phagocytosis was allowed to occur for 1 h as described above, followed by incubation with 300 µg of gentamicin/ml and 100 µg of polymyxin B/ml for 1 h. These antibiotics are unable to penetrate the eukaryotic cell membrane and will kill adherent extracellular, but not internalized, bacterial cells (12). Following this incubation, wells were washed thoroughly with H-H to remove the antibiotics. Wells were then aspirated to remove medium and 1 ml of sterile, distilled H2O was added to each well. Following this osmotic lysis of the monocytes, wells were scraped thoroughly with a rubber policeman. Serial 10-fold dilutions of the well contents were made in PBS (pH 7.4) and plated on BG agar. Plates were incubated at 37°C for 5 days and CFU were determined. Wells lacking monocytes were treated identically to serve as an antibiotic killing control.
| |
RESULTS |
|---|
|
|
|---|
Effects of centrifugation on attachment and phagocytosis. Previous reports have suggested that B. pertussis cells in suspension do not settle significantly over a period of a few hours, and this can affect phagocytosis (27). To assess the effect of centrifugation on phagocytosis by monocytes, duplicate plates of monocytes were prepared. One plate was centrifuged for 5 min at 640 × g to facilitate contact between bacteria and monocytes, while the control plate was left at room temperature. Following centrifugation, phagocytosis was allowed to proceed at 37°C.
Two strains were characterized: the wild type, BP338, and the Bvg mutant strain, BP347. The BvgAS locus is responsible for regulating the expression of a number of virulence factors, including pertussis toxin, adenylate cyclase toxin, FHA, pertactin, and fimbriae. The transposon insertion in the BvgAS locus in BP347 results in an avirulent strain of B. pertussis that fails to express any of the Bvg-regulated virulence factors (43). In the absence of centrifugation, monocytes had a statistically significant reduction in the ability to bind the Bvg mutant strain compared to that of the wild type (Fig. 1A). Centrifugation increased the adherence of the wild type and Bvg mutant to comparable levels.
|
Effects of virulence determinants and LPS on phagocytosis.
Adherence and phagocytosis of the wild type and mutants lacking
specific virulence factors were assessed (Fig.
2). Contrary to results observed in
neutrophils (42), the Bvg-regulated virulence factors FHA
and adenylate cyclase toxin did not influence the adherence or
phagocytosis of B. pertussis by human monocytes (Fig. 2).
However, a small but statistically significant decrease in phagocytosis
was seen for three of the five LPS mutants: WlbG, WlbH, and WlbL (Fig.
2B). Similar results were observed when experiments were repeated using
an MOI of 20 (data not shown).
|
|
Effects of purified pertussis toxin on phagocytosis.
Pertussis
toxin is secreted by B. pertussis and moves through host
cells to the Golgi complex by using the retrograde transport system
(13). In in vitro experiments using cultured mammalian cell lines, intoxication required approximately 1 h
(13). It would be difficult to observe pertussis toxin
effects in the short-term phagocytosis assays, especially if the
bacteria must first secrete the toxin. To overcome these problems, we
pretreated the monocytes with pertussis toxin for 1 h prior to
addition of bacteria. Pertussis toxin pretreatment had no effect on the
adherence of wild-type B. pertussis, BP338, to human
monocytes (Fig. 4A). However, incubation with pertussis toxin at 1.0 ng/ml or greater caused a decrease in the
phagocytic abilities of the monocytes (Fig. 4B). Treatment with
purified B-subunit caused no significant change in phagocytosis, implying that the inhibition requires the catalytic activity of the
toxin. In these studies, bacteria were added at an MOI of 20. No
differences in adherence or uptake following pretreatment of monocytes
with pertussis toxin occurred when experiments were conducted at an MOI
of 5 (data not shown). At an MOI of 5 very few bacteria are
internalized, and it is difficult to discern differences when there are
only a small number of events.
|
Survival of wild-type B. pertussis in human monocytes. Several early reports suggested that B. pertussis was able to survive inside human monocytes and macrophages (15, 20, 29). However, other reports have suggested that intracellular survival is only transient (4, 24) and that B. pertussis kills monocytes and macrophages by inducing apoptosis (1, 5, 35). None of these studies quantified bacterial survival, so we examined survival as a function of the number of bacteria internalized. Antibiotic treatment with polymyxin B and gentamicin was used to eliminate any adherent bacteria, which are bound tightly to the surface of the monocytes and cannot be removed by washing. These antibiotics do not penetrate mammalian cells and will not affect the viability of internalized bacteria. To determine the extent of killing, control wells with no monocytes plated in them were also inoculated with B. pertussis cultures.
Overall, less than 1% of the phagocytosed bacteria could be recovered following lysis of the monocytes (Table 2). For the wild type, Bvg mutant, and WlbL mutant, this number is similar to that in antibiotic control wells lacking monocytes, and the number of bacteria that have survived within the monocytes cannot be distinguished from adherent cells that escaped antibiotic treatment. For one of the two LPS mutant strains tested, WlbG, intracellular survival was similar to that of the wild type but was statistically greater than that in the antibiotic killing control, since WlbG appears to be more sensitive to the polymyxin B and gentamicin treatment. Only 0.02% of the internalized WlbG survived, suggesting that killing is quite efficient.
|
| |
DISCUSSION |
|---|
|
|
|---|
Monocytes/macrophages and neutrophils represent two arms of the innate immune response. It seems reasonable that these two cell types would use different mechanisms to combat invading microorganisms. The differences observed between the present study and previous studies with neutrophils (27, 41, 42) confirm the diversity of the phagocytic defenses, and B. pertussis appears to have successfully evolved a means of evading both types of phagocytic cells. Two virulence factors were shown to influence adherence and phagocytosis of B. pertussis by human neutrophils (41, 42). Strains lacking FHA expression showed a marked reduction in adherence, and adenylate cyclase toxin blocked phagocytosis of bacteria. Based upon these studies, a model of how B. pertussis evades phagocytosis by human neutrophils was developed. Adherence via FHA appears to allow for attachment with little risk of phagocytosis due to a failure to activate signaling mechanisms in neutrophils. If attachment occurs via opsonizing antibodies rather than FHA, adenylate cyclase toxin cripples the phagocytic abilities of neutrophils.
Interestingly, phagocytosis of B. pertussis by monocytes was not different for mutants lacking FHA, adenylate cyclase toxin, or a Bvg mutant lacking all virulence factors. Several studies have demonstrated that FHA and adenylate cyclase toxin exert toxic effects on monocytes and macrophages, including an ability to promote apoptosis (1, 5, 35); however, toxic effects were only observed several hours after treatment. Based on our studies, these virulence factors do not alter the short-term phagocytic abilities of monocytes; however, it is likely that they contribute to the long-term inhibition of monocytes and macrophages that has been observed in response to B. pertussis infection (5, 10, 16, 24, 25).
A role for FHA, pertactin, and fimbriae in influencing attachment and
phagocytosis by monocytes has been reported in previous studies
(17-19, 21, 23). While we did not characterize a mutant lacking only pertactin, characterization of the Bvg mutant, lacking all
adhesins reported to affect phagocytosis, should reflect the role of
this adhesin on phagocytosis. The FHA mutant used in this study is
unable to express both FHA and fimbriae. We did not observe any of
these mutants to be different from the wild type, and the disparity
with previous reports likely resulted from technical differences. In
several studies, the bacteria were chemically labeled with FITC under
highly basic conditions (pH 9.0) to allow visualization by fluorescence
microscopy (17-20, 23). FITC covalently binds to the
-amino groups at the N terminus or the
-amino groups of lysines
on proteins that are exposed on the bacterial surface. FITC labeling
has been shown to inactivate the adenylate cyclase toxin
(39) and is likely to modify other virulence factors as well, making it difficult to be sure that the behavior of FITC-labeled bacteria reflects the behavior of unlabeled bacteria. In this study, we
used B. pertussis expressing GFP in the cytoplasm. GFP does
not affect the growth of the bacteria or alter expression of virulence
factors (39-42).
The studies which reported a role for the adhesins in promoting phagocytosis did not use centrifugation to promote contact between B. pertussis and the phagocytes (17-20). We also observed decreased uptake of a Bvg mutant compared to that of the wild-type strain in the absence of centrifugation (Fig. 1) but not when centrifugation was used to promote association. Similarly, opsonization promoted phagocytosis of bacteria in the absence of centrifugation but had no effect in the presence of centrifugation (Fig. 1). In the human body, monocytes are motile and are capable of pursuing bacteria. In culture, adherent monocytes cannot pursue the bacteria, and contact is most likely to be maintained with bacteria that mediate their own adherence or adhere via the Fc receptors on antibodies. Centrifugation promotes association between the bacteria and monocytes and appears to eliminate the bias toward adherent bacteria. We feel these experimental conditions more closely parallel events in vivo.
LPS appears to influence phagocytosis of B. pertussis by human monocytes, even when centrifugation is used to promote close contact with the bacteria. B. pertussis has an unusually short LPS with a single nonrepeating trisaccharide moiety comprising the O-antigen (6, 8, 36). Five mutants with different deficiencies in production of the trisaccharide were characterized, and three mutants, WlbG, WlbL, and WlbH, showed a statistically significant decrease in internalization compared to the parental strain in the absence of antibody. The WlbG and WlbL mutants lack the trisaccharide (2, 3), while the WlbH mutant only adds the first two sugars of the trisaccharide (2). The susceptibilities of the WlbD and MLT7 mutants to phagocytosis were indistinguishable from that of the wild type in the presence or absence of antibody. The LPS of the WlbD mutant is larger than wild-type LPS and possibly has more than three terminal sugars. The nature of the mutation in MLT7 is unknown, but this mutant synthesizes an LPS that appears to contain only the first sugar of the trisaccharide (2). It is interesting that LPS mutants should be more resistant to phagocytosis than the wild type, although the observed effect was very modest. Monocytes possess specific receptors for LPS. Human toll-like receptor 4 is one of the many phagocytic receptor types exposed on the surface of human monocytes and macrophages. This class of receptor has been shown to specifically signal in response to LPS (9, 26), and it is likely that this receptor family plays a role in the internalization of B. pertussis.
Pertussis toxin is likely to be a key mechanism by which B. pertussis resists phagocytosis by monocytes and macrophages. Pertussis toxin has been shown to inhibit chemotaxis and migration of monocytes to the site of infection (31-33). Furthermore, pertussis toxin has been implicated in inhibiting a number of activities of human phagocytic cells, including phagocytosis and induction of nitric oxide synthesis (22, 45). Thus, in addition to preventing migration to the site of infection, pertussis toxin limits the phagocytic potential of monocytes in the airway. We found that pretreatment of monocytes with pertussis toxin at concentrations as low as 1.0 ng/ml significantly reduced phagocytosis of wild-type BP338. The B-subunit alone was without effect, suggesting a role for ADP ribosylation. The failure to see differences between the wild-type strain and Bvg mutant, which fails to produce pertussis toxin, is likely due to the lag time for pertussis toxin to reach and modify its intracellular target (13). One-hour phagocytosis assays do not allow sufficient time for pertussis toxin activity to be observed.
Opsonization with pooled sera from adult volunteers in this study did not promote phagocytosis when the bacteria were brought into close association with the monocytes by centrifugation. In studies with neutrophils, opsonization did not promote phagocytosis unless neutralizing antibodies to adenylate cyclase toxin were present (41). Opsonization with postimmunization sera from adult participants in a pertussis acellular vaccine study also failed to improve phagocytosis of B. pertussis by neutrophils (40); however, the acellular vaccines do not include the adenylate cyclase toxin as an antigen. Pertussis toxin appears to be the only factor hindering phagocytosis by monocytes. The role of specific antibodies, in particular neutralizing antibodies to pertussis toxin, in promoting phagocytosis by monocytes will be examined in future studies.
Previous reports have suggested that B. pertussis is capable of surviving in monocytes and macrophages (7, 15, 20). Quantitative assessment of intracellular survival in this study suggests that less than 1% of the internalized bacteria survive following phagocytosis, suggesting that monocytes could contribute to clearance of B. pertussis. However, phagocytosis by monocytes does not appear to be very efficient, and a greater understanding of the mechanism by which B. pertussis resists phagocytosis by monocytes is needed.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by grant RO1 AI45715 to A.A.W. L.M.S. was the recipient of a University Distinguished Graduate Assistantship from the University of Cincinnati.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, 231 Albert Sabin Way, ML 0524, Cincinnati, OH 45267. Phone: (513) 558-2820. Fax: (513) 558-8474. E-mail: Alison.Weiss{at}uc.edu.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Abramson, T.,
H. Kedem, and D. A. Relman.
2001.
Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin.
Infect. Immun.
69:2650-2658 |
| 2. | Allen, A., and D. Maskell. 1996. The identification, cloning and mutagenesis of a genetic locus required for lipopolysaccharide biosynthesis in Bordetella pertussis. Mol. Microbiol. 19:37-52[CrossRef][Medline]. |
| 3. | Allen, A. G., R. M. Thomas, J. T. Cadisch, and D. J. Maskell. 1998. Molecular and functional analysis of the lipopolysaccharide biosynthesis locus wlb from Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Mol. Microbiol. 29:27-38[CrossRef][Medline]. |
| 4. | Banemann, A., and R. Gross. 1997. Phase variation affects long-term survival of Bordetella bronchiseptica in professional phagocytes. Infect. Immun. 65:3469-3473[Abstract]. |
| 5. | Boschwitz, J. S., J. W. Batanghari, H. Kedem, and D. A. Relman. 1997. Bordetella pertussis infection of human monocytes inhibits antigen-dependent CD4 T cell proliferation. J. Infect. Dis. 176:678-686[Medline]. |
| 6. | Brodeur, B. R., D. Martin, J. Hamel, R. D. Shahin, and C. Laferriere. 1993. Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis. Semin. Immunopathol. 15:205-215[Medline]. |
| 7. |
Bromberg, K.,
G. Tannis, and P. Steiner.
1991.
Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection.
Infect. Immun.
59:4715-4719 |
| 8. | Caroff, M., J. Brisson, A. Martin, and D. Karibian. 2000. Structure of the Bordetella pertussis 1414 endotoxin. FEBS Lett. 477:8-14[CrossRef][Medline]. |
| 9. |
Chow, J. C.,
D. W. Young,
D. T. Golenbock,
W. J. Christ, and F. Gusovsky.
1999.
Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction.
J. Biol. Chem.
274:10689-10692 |
| 10. |
Confer, D. L., and J. W. Eaton.
1982.
Phagocyte impotence caused by an invasive bacterial adenylate cyclase.
Science
217:948-950 |
| 11. |
Craig-Mylius, K. A., and A. A. Weiss.
2000.
Antibacterial agents and release of periplasmic pertussis toxin from Bordetella pertussis.
Antimicrob. Agents Chemother.
44:1383-1386 |
| 12. |
Drevets, D. A.,
B. P. Canono,
P. J. Leenen, and P. A. Campbell.
1994.
Gentamicin kills intracellular Listeria monocytogenes.
Infect. Immun.
62:2222-2228 |
| 13. | el Baya, A., R. Linnemann, L. von Olleschik-Elbheim, H. Robenek, and M. A. Schmidt. 1997. Endocytosis and retrograde transport of pertussis toxin to the Golgi complex as a prerequisite for cellular intoxication. Eur. J. Cell Biol. 73:40-48[Medline]. |
| 14. |
Fernandez, R. C., and A. A. Weiss.
1994.
Cloning and sequencing of a Bordetella pertussis serum resistance locus.
Infect. Immun.
62:4727-4738 |
| 15. |
Friedman, R. L.,
K. Nordensson,
L. Wilson,
E. T. Akporiaye, and D. E. Yocum.
1992.
Uptake and intracellular survival of Bordetella pertussis in human macrophages.
Infect. Immun.
60:4578-4585 |
| 16. |
Gueirard, P.,
A. Druilhe,
M. Pretolani, and N. Guiso.
1998.
Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo.
Infect. Immun.
66:1718-1725 |
| 17. | Hazenbos, W. L., C. A. B. Geuijen, M. van den Berg, F. R. Mooi, and R. van Furth. 1995. Bordetella pertussis fimbriae bind to human monocytes via the minor fimbrial subunit FimD. J. Infect. Dis. 171:924-929[Medline]. |
| 18. | Hazenbos, W. L., B. M. van den Berg, C. W. Geuijen, F. R. Mooi, and R. van Furth. 1995. Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinases. J. Immunol. 155:3972-3978[Abstract]. |
| 19. |
Hazenbos, W. L.,
B. M. van den Berg,
J. W. van't Wout,
F. R. Mooi, and R. van Furth.
1994.
Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes.
Infect. Immun.
62:4818-4824 |
| 20. | Hellwig, S. M., W. L. Hazenbos, J. G. van de Winkel, and F. R. Mooi. 1999. Evidence for an intracellular niche for Bordetella pertussis in broncho-alveolar lavage cells of mice. FEMS Immunol. Med. Microbiol. 26:203-207[CrossRef][Medline]. |
| 21. | Hellwig, S. M., H. F. van Oirschot, W. L. Hazenbos, A. B. van Spriel, F. R. Mooi, and J. G. van de Winkel. 2001. Targeting to Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis. J. Infect. Dis. 183:871-879[CrossRef][Medline]. |
| 22. |
Hiemstra, P. S.,
A. Annema,
E. F. Schippers, and R. van Furth.
1992.
Pertussis toxin partially inhibits phagocytosis of immunoglobulin G-opsonized Staphylococcus aureus by human granulocytes but does not affect intracellular killing.
Infect. Immun.
60:202-205 |
| 23. |
Ishibashi, Y.,
S. Claus, and D. A. Relman.
1994.
Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18).
J. Exp. Med.
180:1225-1233 |
| 24. | Khelef, N., and N. Guiso. 1995. Induction of macrophage apoptosis by Bordetella pertussis adenylate cyclase-hemolysin. FEMS Microbiol. Lett. 134:27-32[CrossRef][Medline]. |
| 25. |
Khelef, N.,
A. Zychlinsky, and N. Guiso.
1993.
Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin.
Infect. Immun.
61:4064-4071 |
| 26. |
Kirschning, C. J.,
H. Wesche,
T. Merrill Ayres, and M. Rothe.
1998.
Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide.
J. Exp. Med.
188:2091-2097 |
| 27. |
Lenz, D. H.,
C. L. Weingart, and A. A. Weiss.
2000.
Phagocytosed Bordetella pertussis fails to survive in human neutrophils.
Infect. Immun.
68:956-959 |
| 28. | Masure, H. R. 1993. The adenylate cyclase toxin contributes to the survival of Bordetella pertussis within human macrophages. Microb. Pathog. 14:253-260[CrossRef][Medline]. |
| 29. |
Masure, H. R.
1992.
Modulation of adenylate cyclase toxin production as Bordetella pertussis enters human macrophages.
Proc. Natl. Acad. Sci. USA
89:6521-6525 |
| 30. |
McGuirk, P., and K. H. Mills.
2000.
A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines.
Infect. Immun.
68:1383-1390 |
| 31. |
Meade, B. D.,
P. D. Kind,
J. B. Ewell,
P. P. McGrath, and C. R. Manclark.
1984.
In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.
Infect. Immun.
45:718-725 |
| 32. | Meade, B. D., P. D. Kind, and C. R. Manclark. 1985. Altered mononuclear phagocyte function in mice treated with the lymphocytosis promoting factor of Bordetella pertussis. Dev. Biol. Stand. 61:63-74[Medline]. |
| 33. |
Meade, B. D.,
P. D. Kind, and C. R. Manclark.
1984.
Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation.
Infect. Immun.
46:733-739 |
| 34. |
Mills, K. H.,
A. Barnard,
J. Watkins, and K. Redhead.
1993.
Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model.
Infect. Immun.
61:399-410 |
| 35. | Njamkepo, E., F. Pinot, D. Francois, N. Guiso, B. S. Polla, and M. Bachelet. 2000. Adaptive responses of human monocytes infected by Bordetella pertussis: the role of adenylate cyclase hemolysin. J. Cell Physiol. 183:91-99[CrossRef][Medline]. |
| 36. |
Peppler, M. S.
1984.
Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants.
Infect. Immun.
43:224-232 |
| 37. | Turcotte, M. L., D. Martin, B. R. Brodeur, and M. S. Peppler. 1997. Tn5-induced lipopolysaccharide mutations in Bordetella pertussis that affect outer membrane function. Microbiology 143:2381-2394[Abstract]. |
| 38. | Weiner, R. S., and R. R. Mason. 1984. Subfractionation of human blood monocyte subsets with Percoll. Exp. Hematol. 12:800-804[Medline]. |
| 39. |
Weingart, C. L.,
G. Broitman-Maduro,
G. Dean,
S. Newman,
M. Peppler, and A. A. Weiss.
1999.
Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils.
Infect. Immun.
67:4264-4267 |
| 40. |
Weingart, C. L.,
W. A. Keitel,
K. M. Edwards, and A. A. Weiss.
2000.
Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults.
Infect. Immun.
68:7175-7179 |
| 41. |
Weingart, C. L.,
P. S. Mobberley-Schuman,
E. L. Hewlett,
M. C. Gray, and A. A. Weiss.
2000.
Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.
Infect. Immun.
68:7152-7155 |
| 42. |
Weingart, C. L., and A. A. Weiss.
2000.
Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.
Infect. Immun.
68:1735-1739 |
| 43. |
Weiss, A. A.,
E. L. Hewlett,
G. A. Myers, and S. Falkow.
1983.
Tn5-induced mutations affecting virulence factors of Bordetella pertussis.
Infect. Immun.
42:33-41 |
| 44. |
Weiss, A. A.,
A. R. Melton,
K. E. Walker,
C. Andraos-Selim, and J. J. Meidl.
1989.
Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes.
Infect. Immun.
57:2674-2682 |
| 45. | Xing, D. K., C. Canthaboo, and M. J. Corbel. 2000. Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo. Vaccine 18:2110-2119[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|